NIH Grant

New Resilience Publication

Resilience is highly relevant in the context of cancer, and understanding how survivors adapt and potentially thrive following their diagnosis and treatment may provide insights into better supports and interventions to promote healthier survivorship. In this paper, we characterize two different ways to conceptualize and study resilience in cancer survivorship, as a trait and as a process.

NIH Grant UH3 Has Begun!

Drs. Bellizzi and Park received a multi-year grant (UH3) from the National Institutes of Health (NIH) in 2017. After completing a pilot phase with co-sponsors at Yale University, Dr. Tara Sanft, they began active recruitment in early 2019. Recruitment is scheduled to continue until sample saturation is met. For more information, please go to the study webpage, UConn-Yale Cancer Survivorship Study.

New NIH Multi-Year Grant

Drs. Bellizzi and Park received a multi-year grant from the National Institutes of Health (NIH) to study the transition from active cancer treatment to survivorship. They plan to pilot this grant in a one-year phase in 2017, beginning the multi-year recruitment in 2019.